Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DF7V1X
|
|||
| Drug Name |
NKTR 358
|
|||
| Synonyms |
Rezpegaldesleukin; LY 3471851
Click to Show/Hide
|
|||
| Indication | Systemic lupus erythematosus [ICD-11: 4A40.0; ICD-9: 710] | Phase 2 | [1] | |
| Company |
Lilly
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04433585) A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.